摘要
目的 :探讨降纤酶治疗急性脑梗死的短期效果及对血浆纤维蛋白原的影响。方法 :收集2012年5月—2015年3月收治的84例急性脑梗死患者,均采用脑康复、脑复素等药物治疗,将患者随机分为试验组42例,同时给予降纤酶治疗;对照组42例,同时给予安慰剂治疗。观察患者疗效、神经功能缺损评分、血浆纤维蛋白原水平和凝血功能变化情况。结果 :试验组总有效率为95.24%(40/42),高于对照组的73.81%(31/42,P<0.05)。治疗后,试验组神经功能缺损评分、血浆纤维蛋白原水平均低于对照组和治疗前(P<0.05),但两组患者治疗前后的凝血功能无明显变化。试验组不良反应发生率为9.52%(4/42),低于对照组的26.19%(11/42,P<0.05)。结论 :降纤酶治疗急性脑梗死的短期效果较好,而且能改善患者神经功能缺损评分和血浆纤维蛋白原水平,对凝血功能无明显影响。
Objective： To investigate the short term effect of defibrase in the treatment of acute cerebral infarction and its effect of plasma fibrinogen. Methods： Eighty-four cases of acute cerebral infarction treated with brain rehabilitation, cerebrolysin and other drugs in the hospital from May 2012 to March 2015 were collected and divided into an experiment group with 42 cases who were treated with defibrase and a control group with 42 cases treated by placebo. The curative effect, the nerve function defect score, the plasma fibrinogen level and the blood coagulation function change were observed in the patients. Results： The total effective rate of the experiment group was 95.24%（40/42）,which was higher than that of the control group 73.81%（31/42, P〈0.05）. After treatment, the nerve function defect score and plasma fibrinogen level of the experiment group were lower than those of the control group and before treatment（P〈0.05）, but there was no signifcant change of coagulation function in the two groups before and after treatment. The incidence of adverse reactions in the experiment group was 9.52%（4/42）, which was lower than that in the control group 26.19%（11/42, P〈0.05）. Conclusion： The short term effect of the defibrase in the treatment of acute cerebral infarction is better. It can improve the neurological function defect score and plasma fibrinogen level, but it has no significant effect on coagulation function.
出处
《上海医药》
CAS
2016年第22期22-23,39,共3页
Shanghai Medical & Pharmaceutical Journal
关键词
急性脑梗死
降纤酶
短期效果
血浆纤维蛋白原
acute cerebral infarction
defibrase
short term effect
plasma fibrinogen
